Skip to main content

Table 3 Therapeutic control of lipids and office blood pressure at follow-up

From: Secondary prevention after ischaemic stroke: the ASPIRE-S study

 

Proportion reaching target (%)

All patients

On lipid-lowering medication

No lipid-lowering treatment

p-value

Lipid targetsa (mmol/l)

 TC < 5.0

(200) 86.2

(196) 89.5

(4) 30.8

p < 0.001

 TC < 4.5

(174) 75.0

(171) 78.1

(3) 23.1

p < 0.001

 LDL < 2.5

(170) 76.9

(167) 79.5

(3) 27.3

p < 0.001

 LDL < 1.8

(97) 43.9

(96) 45.7

(1) 9.1

p < 0.05

 

All patients

On anti-hypertensive medication

No anti-hypertensive medication

p-value

BP targets (mmHg)

 BP <140/90

(91) 36.6

(62) 33.2

(29) 46.8

P = 0.05

 BP <135/85

(69) 27.7

(46) 24.6

(23) 37.1

P = 0.06

 BP <130/80

(40) 16.1

(24) 12.8

(16) 25.8

p < 0.05

  1. TC total cholesterol, LDL low-density lipoprotein, BP blood pressure
  2. aEuropean Guidelines on cardiovascular disease prevention (version 2012) [15]